11/20/12 - 08:03 AM EST
Alexza expects US and European regulators to announce approval decisions in December.
11/14/12 - 07:01 AM EST
Traders are already bidding up shares of Celsion in anticipation of pivotal trial results.
10/31/12 - 07:00 AM EDT
Supernus share should fall now that 10 million shares under lock-up can now be sold.
10/17/12 - 07:00 AM EDT
Traders need to be less cocky and more prepared for when stocks fall.
10/09/12 - 07:05 AM EDT
The biotech bull market has created a new category of swing trade catalysts.
10/02/12 - 10:48 AM EDT
Biotech swing trader Mark Messier warns to look at Hemispherx as a short-term trade, not an investment.
09/26/12 - 08:00 AM EDT
Get in Zogenix early before other traders start speculating over its chronic pain drug Zohydro.
09/19/12 - 07:31 AM EDT
Biotech trader Mark Messier explains how to position trades ahead of two important biotech clinical trials.
09/11/12 - 11:34 AM EDT
Biotech trader Mark Messier explains how to swing trade Dynavax into a Nov. 14 FDA advisory panel.